Scholars Central

Conference abstractPublished 20 Oct 2016

Antibacterial biopolymer coatings for titanium implants

Authors: Alejandra Rodriguez-Contreras, Jose Maria Manero, Elisa Ruperez, Maria Soledad Marques-Calvo

UniversitÃ?© de MontrÃ?©al, Canada. Universitat PolitÃ?¨cnica de Catalunya-Barcelona TECH, Spain Universitat PolitÃ?¨cnica de Catalunya-Barcelona TECH, Spain

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biomaterial-associated infection is a serious complication of modern implantation surgery. Bacterial adhesion to biomaterials and the presence of biofilms are the main causes to the pathogenesis of implant-associated infections. Therefore, the improvement of implant surfaces is required to avoid the first stage for biofilm formation, bacterial adhesion. The current research addresses this issue by developing drug delivery systems (DDS) consisting on antibiotic-loaded polyhydroxyalkanoates (PHAs) coatings on titanium (Ti) implants. Dip-coating technique was used to achieve optimal coatings with the biodegradable biopolyesters, polyhydroxybutyrate (PHB) and its copolymer, polyhydroxybutyrate-co-hydroxyvalerate (PHBV), testing relevant factors such as drug concentrations and number of immersions. The characterization of the generated coatings was carried out by analysing their wettability-contact angle, topography, thickness and roughness. Studies of drug delivery, toxicity, antibacterial effect, and cell adhesion were also performed. For both biopolymers, results show partially covered surfaces with 1 and 3 dip-coatings, and completely covered ones with 6, showing porous topographies (âÂ?Â?âÂ?Â?50 Ã?¼m). From both biopolymer coatings, the antibiotic gentamicin is released above the minimum inhibitory concentration-MIC without cell toxicity for more than two weeks. Although both biopolymer coatings assure the protection against bacteria populations (bacterial growth inhibition with 1, 3 and 6 dipcoatings), it is considered that the coatings made with PHBV are closer to the desired release profile; a faster degradation of PHBV provides higher and more constant concentrations of drug released in the period of time desired compared to the PHB coatings. The use of coatings with different drug concentration per layers results in more controlled and homogeneous releases. The DDS designed not only assure avoid the first stage of bacterial adhesion and the biofilm formation, but also their proliferation, since the biopolymer coatings with antibiotic degrade with time under physiological conditions, guaranteeing a controlled drug release.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioprocessing & Biotechniques.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioprocessing & Biotechniques
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Alejandra Rodriguez-Contreras”
  • BylineArticles whose byline prints “Jose Maria Manero”
  • BylineArticles whose byline prints “Elisa Ruperez”
  • BylineArticles whose byline prints “Maria Soledad Marques-Calvo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels